ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 618 filers reported holding ISHARES TR in Q2 2018. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,169,000 | +20.6% | 84,386 | -0.5% | 0.07% | +12.9% |
| Q3 2019 | $8,435,000 | -18.1% | 84,768 | -10.2% | 0.06% | -21.5% |
| Q2 2019 | $10,304,000 | -5.0% | 94,425 | -2.7% | 0.08% | -11.2% |
| Q1 2019 | $10,849,000 | +65.7% | 97,027 | +42.9% | 0.09% | +39.1% |
| Q4 2018 | $6,547,000 | -27.4% | 67,885 | -8.1% | 0.06% | -29.7% |
| Q3 2018 | $9,012,000 | +40.6% | 73,893 | +26.6% | 0.09% | +3.4% |
| Q2 2018 | $6,411,000 | -1.6% | 58,381 | -4.4% | 0.09% | -2.2% |
| Q1 2018 | $6,516,000 | -10.3% | 61,048 | -10.3% | 0.09% | -7.2% |
| Q4 2017 | $7,268,000 | -3.7% | 68,067 | +200.9% | 0.10% | -18.5% |
| Q3 2017 | $7,547,000 | -7.6% | 22,619 | -14.1% | 0.12% | -17.4% |
| Q2 2017 | $8,168,000 | +7.8% | 26,336 | +1.9% | 0.14% | -5.9% |
| Q1 2017 | $7,579,000 | +4.1% | 25,846 | -5.8% | 0.15% | -7.3% |
| Q4 2016 | $7,283,000 | +1.3% | 27,443 | +10.4% | 0.16% | -4.6% |
| Q3 2016 | $7,193,000 | +7.8% | 24,847 | -4.2% | 0.17% | -1.1% |
| Q2 2016 | $6,673,000 | – | 25,945 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |